Dicoumarol activates Ca-permeable cation channels triggering erythrocyte cell membrane scrambling

Cellular Physiology and Biochemistry

Volumn 28, Issue 5, 2011, Pages 857-864

  Qadri, Syed M ^a   Kucherenko, Yuliya ^a   Zelenak, Christine ^a   Jilani, Kashif ^a   Lang, Elisabeth ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Calcium; Cell volume; Dicoumarol; Eryptosis; Phosphatidylserine; Scrambling

Indexed keywords

CALCIUM ION; CATION CHANNEL; DICOUMAROL; HEMOGLOBIN; LIPOCORTIN 5; PHOSPHOLIPID; ANILINE DERIVATIVE; ANTICOAGULANT AGENT; CALCIUM; FLUO 3; ION CHANNEL; XANTHENE DERIVATIVE;

ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CELL VOLUME; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; FLUORESCENCE; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN SECRETION; APOPTOSIS; CELL SIZE; CHEMISTRY; DRUG EFFECT; ERYTHROCYTE; METABOLISM; PROTEIN BINDING;

ANILINE COMPOUNDS; ANNEXIN A5; ANTICOAGULANTS; APOPTOSIS; CALCIUM; CELL SIZE; DICUMAROL; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOGLOBINS; HUMANS; ION CHANNELS; PATCH-CLAMP TECHNIQUES; PROTEIN BINDING; XANTHENES;

EID: 83755178192     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335800     Document Type: Article

References (85)

1. Lotrionte M, Castagno D, Agostoni P, Abbate A, Sangiorgi G, Sheiban I, Biondi-Zoccai GG: Long-term effect of chronic oral anticoagulation: focus on coronary artery disease. Future Cardiol 2009;5:259-271.
2. McAlister V: Control of coagulation: A gift of Canadian agriculture. Clin Invest Med 2006;29:373-377. (Pubitemid 46381923)
3. O'Reilly RA: The pharmacodynamics of the oral anticoagulant drugs. Prog Hemost Thromb 1974;2:175-213.
4. Stirling Y: Warfarin-induced changes in procoagulant and anticoagulant proteins. Blood Coagul Fibrinolysis 1995;6:361-373.
5. Nolan KA, Scott KA, Barnes J, Doncaster J, Whitehead RC, Stratford IJ: Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells. Biochem Pharmacol 2010;80:977-981.
6. Scott KA, Barnes J, Whitehead RC, Stratford IJ, Nolan KA: Inhibitors of NQO1: identification of compounds more potent than dicoumarol without associated off-target effects. Biochem Pharmacol 2011;81:355-363.
7. Cabello CM, Bair WB, III, Bause AS, Wondrak GT: Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1. Biochem Pharmacol 2009;78:344-354.
8. Vad NM, Yount G, Moore D, Weidanz J, Moridani MY: Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines. J Pharm Sci 2009;98:1409-1425.
9. Watanabe J, Nishiyama H, Matsui Y, Ito M, Kawanishi H, Kamoto T, Ogawa O: Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines. Oncogene 2006;25:2500-2508.
10. Dong Y, Bey EA, Li LS, Kabbani W, Yan J, Xie XJ, Hsieh JT, Gao J, Boothman DA: Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation. Cancer Res 2010;70:8088-8096.
11. Lee CS, Park SY, Ko HH, Han ES: Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin c in small cell lung cancer cells. Biochem Pharmacol 2004;68:1857-1867. (Pubitemid 39278508)
12. Pardee AB, Li YZ, Li CJ: Cancer therapy with beta-lapachone. Curr Cancer Drug Targets 2002;2:227-242.
13. Wondrak GT: NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. Free Radic Biol Med 2007;43:178-190. (Pubitemid 46977164)
14. Bello RI, Gomez-Diaz C, Lopez-Lluch G, Forthoffer N, Cordoba-Pedregosa MC, Navas P, Villalba JM: Dicoumarol relieves serum withdrawal-induced G0/1 blockade in HL-60 cells through a superoxidedependent mechanism. Biochem Pharmacol 2005;69:1613-1625. (Pubitemid 40719498)
15. Collier AC, Pritsos CA: The mitochondrial uncoupler dicumarol disrupts the MTT assay. Biochem Pharmacol 2003;66:281-287. (Pubitemid 36776401)
16. Gonzalez-Aragon D, Ariza J, Villalba JM: Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells. Biochem Pharmacol 2007;73:427-439. (Pubitemid 44970449)
17. Drucker-Colin RR, Jaques LB, Winocur G: Anemia in sleep-deprived rats receiving anticoagulants. Science 1971;174:505-507.
18. Munday R, Smith BL, Munday CM: Effects of butylated hydroxyanisole and dicoumarol on the toxicity of menadione to rats. Chem Biol Interact 1998;108:155-170. (Pubitemid 28129246)
19. Runciman DJ, Lee AM, Reed KF, Walsh JR: Dicoumarol toxicity in cattle associated with ingestion of silage containing sweet vernal grass (Anthoxanthum odoratum). Aust Vet J 2002;80:28-32. (Pubitemid 135746871)
20. Lang F, Gulbins E, Lerche H, Huber SM, Kempe DS, Föller M: Eryptosis, a window to systemic disease. Cell Physiol Biochem 2008;22:373-380.
21. Bernhardt I, Weiss E, Robinson HC, Wilkins R, Bennekou P: Differential effect of HOE642 on two separate monovalent cation transporters in the human red cell membrane. Cell Physiol Biochem 2007;20:601-606. (Pubitemid 47340620)
22. Duranton C, Huber SM, Lang F: Oxidation induces a Cl-dependent cation conductance in human red blood cells. J Physiol 2002;539:847-855. (Pubitemid 35175434)
23. Duranton C, Huber S, Tanneur V, Lang K, Brand V, Sandu C, Lang F: Electrophysiological properties of the Plasmodium Falciparum-induced cation conductance of human erythrocytes. Cell Physiol Biochem 2003;13:189-198. (Pubitemid 36921037)
24. 2+ leak of human erythrocytes. Cell Physiol Biochem 2008;21:183-192.
25. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, Floride E, Schleicher E, Schulz E, Munzel T, Lang F: Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-1080.
26. Huber SM, Gamper N, Lang F: Chloride conductance and volume-regulatory nonselective cation conductance in human red blood cell ghosts. Pflugers Arch 2001;441:551-558. (Pubitemid 32128152)
27. Kaestner L, Christophersen P, Bernhardt I, Bennekou P: The non-selective voltage-activated cation channel in the human red blood cell membrane: reconciliation between two conflicting reports and further characterisation. Bioelectrochemistry 2000;52:117-125.
28. Kaestner L, Bernhardt I: Ion channels in the human red blood cell membrane: their further investigation and physiological relevance. Bioelectrochemistry 2002;55:71-74. (Pubitemid 34084755)
29. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM: Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-256. (Pubitemid 36553467)
30. Bookchin RM, Ortiz OE, Lew VL: Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 1987;240:193-200.
31. 2+ -dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993;92:520-526. (Pubitemid 23209038)
32. 2+ -activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-C1560. (Pubitemid 37429630)
33. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF, Schulze-Osthoff K, Wesselborg S: Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-1206. (Pubitemid 34048474)
34. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM, Lang F: Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 2003;13:347-356. (Pubitemid 37465150)
35. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C, Huart JJ, Montreuil J, Ameisen JC: Programmed cell death in mature erythrocytes: A model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001;8:1143-1156. (Pubitemid 34048470)
36. Lang F, Gulbins E, Lang PA, Zappulla D, Foller M: Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 2010;26:21-28.
37. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, Wieder T: Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 2004;11:231-243. (Pubitemid 38159647)
38. Lang PA, Kempe DS, Tanneur V, Eisele K, Klarl BA, Myssina S, Jendrossek V, Ishii S, Shimizu T, Waidmann M, Hessler G, Huber SM, Lang F, Wieder T: Stimulation of erythrocyte ceramide formation by platelet-activating factor. J Cell Sci 2005;118:1233-1243. (Pubitemid 40528693)
39. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
40. Barry PH, Lynch JW: Liquid junction potentials and small cell effects in patchclamp analysis. J Membr Biol 1991;121:101-117.
41. Levy G, Lai CM, Yacobi A: Comparative pharmacokinetics of coumarin anticoagulants XXXII: Interindividual differences in binding of warfarin and dicumarol in rat liver and implications for physiological pharmacokinetic modeling. J Pharm Sci 1978;67:229-231. (Pubitemid 8309094)
42. Jing YW, Yi J, Chen YY, Hu QS, Shi GY, Li H, Tang XM: Dicoumarol alters cellular redox state and inhibits nuclear factor kappa B to enhance arsenic trioxideinduced apoptosis. Acta Biochim Biophys Sin (Shanghai) 2004;36:235-242. (Pubitemid 38639059)
43. Hasegawa T, Bando A, Tsuchiya K, Abe S, Okamoto M, Kirima K, Ueno S, Yoshizumi M, Houchi H, Tamaki T: Enzymatic and nonenzymatic formation of reactive oxygen species from 6-anilino-5,8-quinolinequinone. Biochim Biophys Acta 2004;1670:19-27. (Pubitemid 38068360)
44. Mangelus M, Kroyter A, Galron R, Sokolovsky M: Reactive oxygen species regulate signaling pathways induced by M1 muscarinic receptors in PC12M1 cells. J Neurochem 2001;76:1701-1711. (Pubitemid 32221110)
45. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, Lang F: Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-370. (Pubitemid 46671174)
46. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C, Nammi S, Henke G, Myssina S, Krikov M, Huber SM, Wieder T, Lang F: Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004;448:471-477. (Pubitemid 39141524)
47. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B, Risler T, Baur M, Olbricht CJ, Zimmerhackl LB, Zipfel PF, Wieder T, Lang F: Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006;84:378-388. (Pubitemid 43673612)
48. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, Friedrich B, Dreischer P, Wolz C, Schumacher U, Peschel A, Gotz F, Doring G, Wieder T, Gulbins E, Lang F: Suicidal erythrocyte death in sepsis. J Mol Med 2007;85:269-277. (Pubitemid 46295242)
49. Lang PA, Kasinathan RS, Brand VB, Duranton C, Lang C, Koka S, Shumilina E, Kempe DS, Tanneur V, Akel A, Lang KS, Foller M, Kun JF, Kremsner PG, Wesselborg S, Laufer S, Clemen CS, Herr C, Noegel AA, Wieder T, Gulbins E, Lang F, Huber SM: Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency. Cell Physiol Biochem 2009;24:415-428.
50. Bobbala D, Alesutan I, Foller M, Huber SM, Lang F: Effect of anandamide in Plasmodium Berghei-infected mice. Cell Physiol Biochem 2010;26:355-362.
51. Koka S, Bobbala D, Lang C, Boini KM, Huber SM, Lang F: Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2009;23:191-198.
52. Foller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F: Suicide for survivaldeath of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 2009;24:133-140.
53. Siraskar B, Ballal A, Bobbala D, Foller M, Lang F: Effect of amphotericin B on parasitemia and survival of plasmodium berghei-infected mice. Cell Physiol Biochem 2010;26:347-354.
54. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rubben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Haussinger D, Gulbins E, Lang F: Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007;13:164-170.
55. Zappulla D: Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases J Cardiometab Syndr 2008;3:30-34.
56. Gatidis S, Foller M, Lang F: Hemininduced suicidal erythrocyte death. Ann Hematol 2009;88:721-726.
57. Eberhard M, Ferlinz K, Alizzi K, Cacciato PM, Faggio C, Foller M, Lang F: FTY720-induced suicidal erythrocyte death. Cell Physiol Biochem 2010;26:761-766.
58. Bhavsar SK, Eberhard M, Bobbala D, Lang F: Monensin induced suicidal erythrocyte death. Cell Physiol Biochem 2010;25:745-752.
59. Bhavsar SK, Bobbala D, Xuan NT, Foller M, Lang F: Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol Biochem 2010;26:859-868.
60. Mahmud H, Mauro D, Qadri SM, Foller M, Lang F: Triggering of suicidal erythrocyte death by amphotericin B. Cell Physiol Biochem 2009;24:263-270.
61. Braun M, Foller M, Gulbins E, Lang F: Eryptosis triggered by bismuth. Biometals 2009;22:453-460.
62. Mahmud H, Foller M, Lang F: Arsenicinduced suicidal erythrocyte death. Arch Toxicol 2009;83:107-113.
63. Mahmud H, Dalken B, Wels WS: Induction of programmed cell death in ErbB2/HER2-expressing cancer cells by targeted delivery of apoptosis-inducing factor. Mol Cancer Ther 2009;8:1526-1535.
64. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M, Hofmann F, Schuler B, Vogel J, Pichler B, Kasinathan RS, Nicolay JP, Huber SM, Lang F, Feil R: Anemia and splenomegaly in cGKIdeficient mice. Proc Natl Acad Sci USA 2008;105:6771-6776.
65. Andrews DA, Low PS: Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82. (Pubitemid 29342520)
66. Closse C, Dachary-Prigent J, Boisseau MR: Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-302. (Pubitemid 29530214)
67. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS: Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-4627. (Pubitemid 36857838)
68. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L, Di Tomo P, Capani F, Consoli A, Bonomini M: Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709. (Pubitemid 350058263)
69. Wood BL, Gibson DF, Tait JF: Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-1880. (Pubitemid 26307087)
70. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, Chung JH: Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-421.
71. Zwaal RF, Comfurius P, Bevers EM: Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-988. (Pubitemid 40655614)
72. Berridge MJ, Lipp P, Bootman MD: The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000;1:11-21.
73. 2+ entry resulting in apoptosis. J Neurochem 2008;104:1177-1189.
74. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998;281:1309-1312. (Pubitemid 28406816)
75. Liu XH, Kirschenbaum A, Yu K, Yao S, Levine AC: Cyclooxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line. J Biol Chem 2005;280:3817-3823. (Pubitemid 40223851)
76. Parekh AB, Penner R: Store depletion and calcium influx. Physiol Rev 1997;77:901-930. (Pubitemid 27459576)
77. Spassova MA, Soboloff J, He LP, Hewavitharana T, Xu W, Venkatachalam K, van Rossum DB, Patterson RL, Gill DL: Calcium entry mediated by SOCs and TRP channels: variations and enigma. Biochim Biophys Acta 2004;1742:9-20. (Pubitemid 39601764)
78. Svoboda N, Pruetting S, Grissmer S, Kerschbaum HH: cAMP-dependent chloride conductance evokes ammoniainduced blebbing in the microglial cell line, BV-2. Cell Physiol Biochem 2009;24:53-64.
79. Arboleda G, Huang TJ, Waters C, Verkhratsky A, Fernyhough P, Gibson RM: Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells. Eur J Neurosci 2007;25:3030-3038. (Pubitemid 46888810)
80. Arboleda G, Cardenas Y, Rodriguez Y, Morales LC, Matheus L, Arboleda H: Differential regulation of AKT, MAPK and GSK3beta during C(2)-ceramideinduced neuronal death. Neurotoxicology 2010;31:687-693.
81. Costantini C, Scrable H, Puglielli L: An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generation. EMBO J 2006;25:1997-2006.
82. Gulbins E, Szabo I, Baltzer K, Lang F: Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci USA 1997;94:7661-7666. (Pubitemid 27345373)
83. Gulbins E, Jekle A, Ferlinz K, Grassme H, Lang F: Physiology of apoptosis. Am J Physiol Renal Physiol 2000;279:F605-F615.
84. Kirschnek S, Paris F, Weller M, Grassme H, Ferlinz K, Riehle A, Fuks Z, Kolesnick R, Gulbins E: CD95-mediated apoptosis in vivo involves acid sphingomyelinase. J Biol Chem 2000;275:27316-27323.
85. Teichgraber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kurthy G, Schmid KW, Weller M, Tummler B, Lang F, Grassme H, Doring G, Gulbins E: Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008;14:382-391. (Pubitemid 351499396)